Mohammed Safi

Sulfadoxine-Pyrimethamine, Chlorproguanil-Dapsone, or Chloroquine for the Treatment of Plasmodium vivax Malaria in Afghanistan and Pakistan

Toby Leslie, Mohammad I Mayan, Mahdi Hasan et al. · JAMA · 2007 · 79 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients

Abdullah Al-Danakh, Mohammed Safi, Yuli Jian et al. · Frontiers in Immunology · 2024 · 33 citations · Full text

Life Sciences, Immunology, Oncology +17

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study

Mohammed Safi, Mahmoud Al‐Azab, Chenxing Jin et al. · Frontiers in Immunology · 2021 · 16 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study

Abdullah Al-Danakh, Mohammed Safi, Mohammed Alradhi et al. · Cells · 2022 · 13 citations · Full text

Medicine, Immunology, Oncology +17

Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma

Salem Baldi, Hassan Khamgan, Yuanyuan Qian et al. · Frontiers in Oncology · 2021 · 12 citations · Full text

Life Sciences, Genetics, Oncology +17